Nicotine Gums And Lozenges Market is expected to reach US$ 6.86 Bn. at a CAGR of 4.8 during the forecast period 2029. Nicotine gum is in a class of medications called smoking cessation aids. It works by providing nicotine to your body to decrease the withdrawal symptoms experienced when smoking is stopped and as a substitute oral activity to reduce the urge to smoke.To know about the Research Methodology :- Request Free Sample Report Lozenges used to treat sore throats, coughs, and other throat irritations. Common lozenges includes Chloraseptic, Delsym and Vicks. The report on the Global Nicotine Gums and Lozenges Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecast period from 2023 to 2029. The market is divided into various segments like Application, and Region with an in-depth outlook of the competitors and a listing of the profiled key players. Some of major key players in the global market includes Johnson & Johnson, Revolymer, GlaxoSmithKline, Dr.Reddy's Laboratories, Lupin Pharma. The market size in terms of revenue and volume is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Nicotine Gums and Lozenges Market DYNAMICS
Drug abuse and addiction have so many dimensions and disrupt so many aspects of an individual’s life and the treatment is not simple. The nicotine gums and lozenges are more appropriate form of primary therapy for smoking cessation in those with normal hearts. Rising awareness regarding health hazards associated with smoking is the reason for vast production & utilization of nicotine gums and lozenges from the pharmacy companies and end users. Scientific research and clinical practice demonstrate the value of nicotine gums and lozenges in treating addiction, with a variety of approaches having been tested and integrated in residential and community settings. The Nicotine gums and lozenges achieves the ultimate goal of sustained abstinence and recovery of patients’ lives, hence the global market is boosting in the forecast period of 2023-2029.Nicotine Gums and Lozenges Market Competitive Landscape
GlaxoSmithKline is one of the prominent key players in the global nicotine gums and lozenges market. The company manufacturers and developed innovative nicotine replacement therapies and smoking cessation products. In 2019, GlaxoSmithKline under the brand name Nicorette has launch new nicotine gum coated ice mint lozenge with a smoother texture. Dr. Reddy’s Laboratories is one of the leading pharmaceutical companies that has strong pharmaceutical value chain network. The company business operations includes basic research, finished dosages, generics, bulk actives and biotechnology. With the development in their pharmaceutical services that includes proprietary products & active ingredients. For instance, in 2019, they have launched nicotine polacrilex lozenges in the US market. Nicotine Gums and Lozenges Market is segmented by Application, and Region. Medical Practise commended the largest market share of xx% by 2029. Nicotine gums and lozenges are the appropriate treatment of alcohol withdrawal (AW) can relieve the patient’s discomfort, prevent the development of more serious symptoms, and forestall cumulative effects that might worsen future individual’s health. Although many patients with mild to moderate tobacco addiction are treated successfully by concern them regarding nicotine gums and lozenges, which drives the global market in the forecast period. Medical practitioners have seen the vast research and development opportunities in nicotine gums and lozenges, and hence, many pharmaceutical organizations, now and in future also they are trying to launch the nicotine replacement therapy products to reduce the deaths occur by drug addiction. North America holds significant share of xx% in the global nicotine gums and lozenges market. Increase in number of health consciousness consumers and growing drug addiction tendency due to hectic lifestyles is driving the global market in the forecast period. Governments and non-government organisations arrange the campaigns for alcohol withdrawal treatment and forced the drug addict population to turn towards drug-free lifestyle and achieve productive functioning in the family, at work, and in society. North America has the presence of major brands focusing on product innovation to capture growing brands and trying to achieve competitive advantage in the global nicotine gums and lozenges market. The facts those are mentioned above are the drivers for the global market in the North America.Scope of Global Nicotine Gums and Lozenges Market : Inquire before buying
Global Nicotine Gums and Lozenges Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: US $ 4.94 Bn. Forecast Period 2023 to 2029 CAGR: 4.8% Market Size in 2029: US $ 6.86 Bn. Segments Covered: by Application • Medical Practice • Individual Smokers • Others Nicotine Gums and Lozenges Market, by Region
• North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)Nicotine Gums and Lozenges Market Key Players are:
• Novartis • Cambrex Corporation • Fertin Pharma • Perrigo Company • Alchem International • Pharmacia • Reynolds American • Johnson & Johnson • Revolymer • GlaxoSmithKline • Dr. Reddy's Laboratories • Lupin Pharma • British American Tobacco, • ITC Limited Frequently Asked questions 1. Which region has the largest share in Global Nicotine Gums and Lozenges Market? Ans: Asia Pacific region held the highest share in 2022. 2. What is the growth rate of Global Nicotine Gums and Lozenges Market? Ans: The Global Nicotine Gums and Lozenges Market is growing at a CAGR of 4.8% during forecasting period 2023-2029. 3. What is scope of the Global Nicotine Gums and Lozenges Market report? Ans: Global Nicotine Gums and Lozenges Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Nicotine Gums and Lozenges Market? Ans: The important key players in the Global Nicotine Gums and Lozenges Market are – Novartis, Cambrex Corporation, Fertin Pharma, Perrigo Company, Alchem International, Pharmacia, Reynolds American, Johnson & Johnson, Revolymer,GlaxoSmithKline. 5. What is the study period of this Market? Ans: The Global Nicotine Gums and Lozenges Market is studied from 2022 to 2029.
Global Nicotine Gums And Lozenges Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Nicotine Gums and Lozenges Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Nicotine Gums and Lozenges Market Analysis and Forecast 6.1. Global Nicotine Gums and Lozenges Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Nicotine Gums and Lozenges Market Analysis and Forecast, By Application 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Nicotine Gums and Lozenges Market Value Share Analysis, By Application 7.4. Global Nicotine Gums and Lozenges Market Size (US$ Mn) Forecast, By Application 7.5. Global Nicotine Gums and Lozenges Market Analysis, By Application 7.6. Global Nicotine Gums and Lozenges Market Attractiveness Analysis, By Application 8. Global Nicotine Gums and Lozenges Market Analysis, By Region 8.1. Global Nicotine Gums and Lozenges Market Value Share Analysis, By Region 8.2. Global Nicotine Gums and Lozenges Market Size (US$ Mn) Forecast, By Region 8.3. Global Nicotine Gums and Lozenges Market Attractiveness Analysis, By Region 9. North America Global Nicotine Gums and Lozenges Market Analysis 9.1. Key Findings 9.2. North America Global Nicotine Gums and Lozenges Market Overview 9.3. North America Global Nicotine Gums and Lozenges Market Value Share Analysis, By Application 9.4. North America Global Nicotine Gums and Lozenges Market Forecast, By Application 9.4.1. Medical Practice 9.4.2. Individual Smokers 9.4.3. Others 9.5. North America Global Nicotine Gums and Lozenges Market Value Share Analysis, By Component 9.6. North America Global Nicotine Gums and Lozenges Market Value Share Analysis, By Country 9.7. North America Global Nicotine Gums and Lozenges Market Forecast, By Country 9.7.1. U.S. 9.7.2. Canada 9.7.3. Mexico 9.8. North America Global Nicotine Gums and Lozenges Market Analysis, By Country 9.9. U.S. Global Nicotine Gums and Lozenges Market Forecast, By Application 9.9.1. Medical Practice 9.9.2. Individual Smokers 9.9.3. Others 9.10. Canada Global Nicotine Gums and Lozenges Market Forecast, By Application 9.10.1. Medical Practice 9.10.2. Individual Smokers 9.10.3. Others 9.11. Mexico Global Nicotine Gums and Lozenges Market Forecast, By Application 9.11.1. Medical Practice 9.11.2. Individual Smokers 9.11.3. Others 9.12. North America Global Nicotine Gums and Lozenges Market Attractiveness Analysis 9.12.1. By Application 9.13. PEST Analysis 9.14. Key Trends 9.15. Key Developments 10. Europe Global Nicotine Gums and Lozenges Market Analysis 10.1. Key Findings 10.2. Europe Global Nicotine Gums and Lozenges Market Overview 10.3. Europe Global Nicotine Gums and Lozenges Market Value Share Analysis, By Application 10.4. Europe Global Nicotine Gums and Lozenges Market Forecast, By Application 10.4.1. Medical Practice 10.4.2. Individual Smokers 10.4.3. Others 10.5. Europe Global Nicotine Gums and Lozenges Market Value Share Analysis, By Country 10.6. Europe Global Nicotine Gums and Lozenges Market Forecast, By Country 10.6.1. Germany 10.6.2. U.K. 10.6.3. France 10.6.4. Italy 10.6.5. Spain 10.6.6. Sweden 10.6.7. CIS countries 10.6.8. Rest of Europe 10.7. Germany Global Nicotine Gums and Lozenges Market Forecast, By Application 10.7.1. Medical Practice 10.7.2. Individual Smokers 10.7.3. Others 10.8. U.K. Global Nicotine Gums and Lozenges Market Forecast, By Application 10.8.1. Medical Practice 10.8.2. Individual Smokers 10.8.3. Others 10.9. France Global Nicotine Gums and Lozenges Market Forecast, By Application 10.9.1. Medical Practice 10.9.2. Individual Smokers 10.9.3. Others 10.10. Italy Global Nicotine Gums and Lozenges Market Forecast, By Application 10.10.1. Medical Practice 10.10.2. Individual Smokers 10.10.3. Others 10.11. Spain Global Nicotine Gums and Lozenges Market Forecast, By Application 10.11.1. Medical Practice 10.11.2. Individual Smokers 10.11.3. Others 10.12. Sweden Global Nicotine Gums and Lozenges Market Forecast, By Application 10.12.1. Medical Practice 10.12.2. Individual Smokers 10.12.3. Others 10.13. CIS countries Global Nicotine Gums and Lozenges Market Forecast, By Application 10.13.1. Medical Practice 10.13.2. Individual Smokers 10.13.3. Others 10.14. Rest of Europe Global Nicotine Gums and Lozenges Market Forecast, By Application 10.14.1. Medical Practice 10.14.2. Individual Smokers 10.14.3. Others 10.15. Europe Global Nicotine Gums and Lozenges Market Attractiveness Analysis 10.15.1. By Application 10.16. PEST Analysis 10.17. Key Trends 10.18. Key Developments 11. Asia Pacific Global Nicotine Gums and Lozenges Market Analysis 11.1. Key Findings 11.2. Asia Pacific Global Nicotine Gums and Lozenges Market Overview 11.3. Asia Pacific Global Nicotine Gums and Lozenges Market Value Share Analysis, By Application 11.4. Asia Pacific Global Nicotine Gums and Lozenges Market Forecast, By Application 11.4.1. Medical Practice 11.4.2. Individual Smokers 11.4.3. Others 11.5. Asia Pacific Global Nicotine Gums and Lozenges Market Value Share Analysis, By Country 11.6. Asia Pacific Global Nicotine Gums and Lozenges Market Forecast, By Country 11.6.1. China 11.6.2. India 11.6.3. Japan 11.6.4. South Korea 11.6.5. Australia 11.6.6. ASEAN 11.6.7. Rest of Asia Pacific 11.7. Asia Pacific Global Nicotine Gums and Lozenges Market Analysis, By Country 11.8. China Global Nicotine Gums and Lozenges Market Forecast, By Application 11.8.1. Medical Practice 11.8.2. Individual Smokers 11.8.3. Others 11.9. India Global Nicotine Gums and Lozenges Market Forecast, By Application 11.9.1. Medical Practice 11.9.2. Individual Smokers 11.9.3. Others 11.10. Japan Global Nicotine Gums and Lozenges Market Forecast, By Application 11.10.1. Medical Practice 11.10.2. Individual Smokers 11.10.3. Others 11.11. South Korea Global Nicotine Gums and Lozenges Market Forecast, By Application 11.11.1. Medical Practice 11.11.2. Individual Smokers 11.11.3. Others 11.12. Australia Global Nicotine Gums and Lozenges Market Forecast, By Application 11.12.1. Medical Practice 11.12.2. Individual Smokers 11.12.3. Others 11.13. ASEAN Global Nicotine Gums and Lozenges Market Forecast, By Application 11.13.1. Medical Practice 11.13.2. Individual Smokers 11.13.3. Others 11.14. Rest of Asia Pacific Global Nicotine Gums and Lozenges Market Forecast, By Application 11.14.1. Medical Practice 11.14.2. Individual Smokers 11.14.3. Others 11.15. Asia Pacific Global Nicotine Gums and Lozenges Market Attractiveness Analysis 11.15.1. By Application 11.16. PEST Analysis 11.17. Key Trends 11.18. Key Developments 12. Middle East & Africa Global Nicotine Gums and Lozenges Market Analysis 12.1. Key Findings 12.2. Middle East & Africa Global Nicotine Gums and Lozenges Market Overview 12.3. Middle East & Africa Global Nicotine Gums and Lozenges Market Value Share Analysis, By Application 12.4. Middle East & Africa Global Nicotine Gums and Lozenges Market Forecast, By Application 12.4.1. Medical Practice 12.4.2. Individual Smokers 12.4.3. Others 12.5. Middle East & Africa Global Nicotine Gums and Lozenges Market Value Share Analysis, By Country 12.6. Middle East & Africa Global Nicotine Gums and Lozenges Market Forecast, By Country 12.6.1. GCC Countries 12.6.2. South Africa 12.6.3. Nigeria 12.6.4. Egypt 12.6.5. Rest of Middle East & Africa 12.7. Middle East & Africa Global Nicotine Gums and Lozenges Market Analysis, By Country 12.8. GCC Countries Global Nicotine Gums and Lozenges Market Forecast, By Application 12.8.1. Medical Practice 12.8.2. Individual Smokers 12.8.3. Others 12.9. South Africa Global Nicotine Gums and Lozenges Market Forecast, By Application 12.9.1. Medical Practice 12.9.2. Individual Smokers 12.9.3. Others 12.10. Nigeria Global Nicotine Gums and Lozenges Market Forecast, By Application 12.10.1. Medical Practice 12.10.2. Individual Smokers 12.10.3. Others 12.11. Egypt Global Nicotine Gums and Lozenges Market Forecast, By Application 12.11.1. Medical Practice 12.11.2. Individual Smokers 12.11.3. Others 12.12. Rest of Middle East & Africa Global Nicotine Gums and Lozenges Market Forecast, By Application 12.12.1. Medical Practice 12.12.2. Individual Smokers 12.12.3. Others 12.13. Middle East & Africa Global Nicotine Gums and Lozenges Market Attractiveness Analysis 12.13.1. By Application 12.14. PEST Analysis 12.15. Key Trends 12.16. Key Developments 13. South America Global Nicotine Gums and Lozenges Market Analysis 13.1. Key Findings 13.2. South America Global Nicotine Gums and Lozenges Market Overview 13.3. South America Global Nicotine Gums and Lozenges Market Value Share Analysis, By Application 13.4. South America Global Nicotine Gums and Lozenges Market Forecast, By Application 13.4.1. Medical Practice 13.4.2. Individual Smokers 13.4.3. Others 13.5. South America Global Nicotine Gums and Lozenges Market Value Share Analysis, By Country 13.6. South America Global Nicotine Gums and Lozenges Market Forecast, By Country 13.6.1. Brazil 13.6.2. Colombia 13.6.3. Argentina 13.6.4. Rest of South America 13.7. South America Global Nicotine Gums and Lozenges Market Analysis, By Country 13.8. Brazil Global Nicotine Gums and Lozenges Market Forecast, By Application 13.8.1. Medical Practice 13.8.2. Individual Smokers 13.8.3. Others 13.9. Colombia Global Nicotine Gums and Lozenges Market Forecast, By Application 13.9.1. Medical Practice 13.9.2. Individual Smokers 13.9.3. Others 13.10. Argentina Global Nicotine Gums and Lozenges Market Forecast, By Application 13.10.1. Medical Practice 13.10.2. Individual Smokers 13.10.3. Others 13.11. Rest of South America Global Nicotine Gums and Lozenges Market Forecast, By Application 13.11.1. Medical Practice 13.11.2. Individual Smokers 13.11.3. Others 13.12. South America Global Nicotine Gums and Lozenges Market Attractiveness Analysis 13.12.1. By Application 13.13. PEST Analysis 13.14. Key Trends 13.15. Key Developments 14. Company Profiles 14.1. Market Share Analysis, By Company 14.2. Competition Matrix 14.2.1. Competitive Benchmarking of key players By price, presence, market share, Component, and R&D investment 14.2.2. New Product Launches and Product Enhancements 14.2.3. Market Consolidation 14.2.3.1. M&A By Regions, Investment and Component 14.2.3.2. M&A Key Players, Forward Integration and Backward Integration 14.3. Company Profiles: Key Players 14.3.1. Novartis 14.3.1.1. Company Overview 14.3.1.2. Financial Overview 14.3.1.3. Product Portfolio 14.3.1.4. Business Strategy 14.3.1.5. Recent Developments 14.3.1.6. Development Footprint 14.3.2. Cambrex Corporation 14.3.3. Fertin Pharma 14.3.4. Perrigo Company 14.3.5. Alchem International 14.3.6. Pharmacia 14.3.7. Reynolds American 14.3.8. Johnson & Johnson 14.3.9. Revolymer 14.3.10. GlaxoSmithKline 14.3.11. Dr. Reddy's Laboratories 14.3.12. Lupin Pharma 14.3.13. British American Tobacco, 14.3.14. ITC Limited 15. Primary Key Insights